Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How Has the Liquid Biopsy Market Size Shifted in Recent Years?
Over the past few years, the liquid biopsy market has experienced rapid expansion. The market size is projected to increase from $1.25 billion in 2024 to $1.46 billion in 2025, with a compound annual growth rate (CAGR) of 16.1%.
Factors such as progress in cancer studies, non-invasiveness, tailored medicine, regulatory approvals, and early cancer detection have contributed to the growth during the historic period.
In the coming years, the market size of liquid biopsy is anticipated to witness a swift expansion, reaching a value of $2.7 billion by 2029 with a CAGR of 16.7%. This growth during the forecast period is likely due to extending applications, cancer surveillance, the rise of new technologies, companion diagnostics, and biomarker identification.
The forecast period is also expected to see key trends such as cancer diagnosis and monitoring, therapeutic tracking, minimal residual disease (mrd) monitoring, and the use of liquid biopsy in non-oncological applications.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Which Market Conditions Are Fueling the Growth of the Liquid Biopsy Industry?
The expansion of the liquid biopsy market is fueled by government funding aimed at enhancing cancer detection methods. Such funding aids scientific research into drug discovery, detection, and disease management, including cancer.
For instance, the National Institute of Health (NIH), a medical research agency based in the US, received a grant of $46.6 billion in 2022, and the National Cancer Institute (NCI), an American cancer research institution, was given $6.9 billion to advance their cancer research. Consequently, these government contributions have a profound and positive influence on the growth of the liquid biopsy market.
Performance of Leading Segments in the Liquid Biopsy Global Market
The liquid biopsymarket covered in this report is segmented –
1) By Product: Assays Kits; Instruments; Services
2) By Clinical Application: Early Cancer Screening; Therapy Selection; Treatment Monitoring; Recurrence Monitoring Orthopedics
3) By End User: Reference Laboratories; Hospitals and Physician Laboratories; Academic and Research Centers
Subsegments:
1) By Assays Kits: cfDNA Assays; ctDNA Assays; Exosome-based Assays; RNA-based Assays; Protein-based Assays
2) By Instruments: PCR Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; Mass Spectrometry Instruments
3) By Services: Testing Services; Data Analysis Services; Laboratory Services; Custom Assay Development Services
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What Trends Will Shape the Evolution of the Liquid Biopsy Market?
Firms are swiftly embracing new market trends and mainly concentrating on the introduction of cutting-edge products to cater to the escalating demand for liquid biopsy treatments and goods, with the aim of boosting their profits and acquiring a competitive advantage over other contenders. For example, in June 2023, Laboratory Corporation of America Holdings, an American healthcare firm, introduced a liquid biopsy examination named, Labcorp Plasma Focus.
The test is engineered to detect cancer-related biomarkers in people suffering from advanced or metastatic solid tumors.
This test analyzes the cell-free DNA (cfDNA) present in a patient’s blood sample to formulate a genomic outline of their tumor.
The information thus devised is then used by oncologists to improve their patient’s health management by curating personalized, specifically-targeted therapy plans. Therefore, businesses are investing substantial amounts in producing high-tech products in the liquid biopsy market.
What Are the Regional Hotspots for Liquid Biopsy Market Growth?
North America was the largest region in the liquid biopsy market in 2024. Western Europe was the second largest region in the liquid biopsy market.
The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Companies Hold the Largest Market Share in the Liquid Biopsy Industry?
Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…px?id=2815
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
